FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:580 August 19, 1993 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Although a causal relation between human T-cell lymphotropic retrovirus type I and type II (HTLV-I and HTLV-II) and adult T-cell leukemia has been well established, the association between HTLVs and the cutaneous T-cell neoplasm mycosis fungoides has remained controversial. Few patients with mycosis fungoides are seropositive for antibodies to structural components of HTLV I and II virions; a typical figure is about 15 percent. When HTLV-I- or HTLV-II-related proviral DNA sequences have been detected, they have often been found to be incomplete^1,2,3. Nonetheless, cultures of peripheral-blood mononuclear cells from the majority of patients with mycosis fungoides . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Foote, M. (1998). The Importance of Planned Dose of Chemotherapy on Time: Do We Need to Change Our Clinical Practice?. The Oncologist 3: 365-368 [Full Text]  
• Berger, T. G., Kerschmann, R. L., Roth, R., Schulze, K., Zackheim, H. S. (1995). Sezary's Syndrome and Human Immunodeficiency Virus Infection. Arch Dermatol 131: 739-741 [Abstract]